GCM
Gables Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $441K | Hold |
1,087
| – | – | 0.21% | 86 |
|
2025
Q1 | $541K | Hold |
1,087
| – | – | 0.27% | 74 |
|
2024
Q4 | $565K | Hold |
1,087
| – | – | 0.27% | 71 |
|
2024
Q3 | $672K | Buy |
1,087
+12
| +1% | +$7.42K | 0.34% | 64 |
|
2024
Q2 | $594K | Hold |
1,075
| – | – | 0.31% | 64 |
|
2024
Q1 | $625K | Hold |
1,075
| – | – | 0.34% | 63 |
|
2023
Q4 | $571K | Hold |
1,075
| – | – | 0.35% | 63 |
|
2023
Q3 | $544K | Hold |
1,075
| – | – | 0.38% | 59 |
|
2023
Q2 | $561K | Hold |
1,075
| – | – | 0.37% | 61 |
|
2023
Q1 | $620K | Buy |
1,075
+8
| +0.7% | +$4.61K | 0.43% | 55 |
|
2022
Q4 | $588K | Hold |
1,067
| – | – | 0.43% | 56 |
|
2022
Q3 | $541K | Hold |
1,067
| – | – | 0.43% | 53 |
|
2022
Q2 | $580K | Hold |
1,067
| – | – | 0.44% | 55 |
|
2022
Q1 | $630K | Hold |
1,067
| – | – | 0.4% | 57 |
|
2021
Q4 | $712K | Hold |
1,067
| – | – | 0.42% | 57 |
|
2021
Q3 | $610K | Sell |
1,067
-40
| -4% | -$22.9K | 0.4% | 62 |
|
2021
Q2 | $558K | Hold |
1,107
| – | – | 0.38% | 66 |
|
2021
Q1 | $505K | Hold |
1,107
| – | – | 0.28% | 81 |
|
2020
Q4 | $516K | Hold |
1,107
| – | – | 0.3% | 76 |
|
2020
Q3 | $489K | Sell |
1,107
-50
| -4% | -$22.1K | 0.32% | 72 |
|
2020
Q2 | $419K | Hold |
1,157
| – | – | 0.29% | 76 |
|
2020
Q1 | $328K | Buy |
1,157
+54
| +5% | +$15.3K | 0.27% | 79 |
|
2019
Q4 | $358K | Sell |
1,103
-110
| -9% | -$35.7K | 0.24% | 87 |
|
2019
Q3 | $353K | Hold |
1,213
| – | – | 0.25% | 88 |
|
2019
Q2 | $356K | Hold |
1,213
| – | – | 0.29% | 72 |
|
2019
Q1 | $332K | Hold |
1,213
| – | – | 0.27% | 80 |
|
2018
Q4 | $271K | Hold |
1,213
| – | – | 0.24% | 87 |
|
2018
Q3 | $296K | Hold |
1,213
| – | – | 0.23% | 90 |
|
2018
Q2 | $251K | Buy |
1,213
+20
| +2% | +$4.14K | 0.2% | 90 |
|
2018
Q1 | $246K | Buy |
+1,193
| New | +$246K | 0.22% | 90 |
|